Trials / Completed
CompletedNCT03932045
A Study to Evaluate the Safety and Efficacy of SYB Filler(SF-01) in the Correction of Nasolabial Folds
A Randomized, Subject & Evaluator-blind, Matched Pairs, Prospective Study to Compare the Safety and Efficacy Between SYB Filler (SF-01) and Ellansé M in the Correction of Nasolabial Folds
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 59 (actual)
- Sponsor
- Samyang Biopharmaceuticals Corporation · Industry
- Sex
- All
- Age
- 20 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this clinical trial is to verify the safety and efficacy of SYB Filler (SF-01) in the temporary improvement of Nasolabial Folds.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | SYB Filler (SF-01) | Apply up to 1.0 ml of the test device (SF-01) and the contrast device (Ellansé M) to both sides of the nasolabial fold. |
| DEVICE | Ellansé M | Apply up to 1.0 ml of the test device (SF-01) and the contrast device (Ellansé M) to both sides of the nasolabial fold. |
Timeline
- Start date
- 2018-10-08
- Primary completion
- 2020-09-15
- Completion
- 2022-08-12
- First posted
- 2019-04-30
- Last updated
- 2022-11-22
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT03932045. Inclusion in this directory is not an endorsement.